Miyanishi Masanori

Affiliation and department：

Research field (2)： Hematology and oncology , Medical biochemistry

Research keywords (2)：スクリーニング , 造血幹細胞

Research theme for competitive and other funds (1)：

2023 - 2026 Elucidation of the mechanism of rituximab-induced long-term remission in childhood nephrotic syndrome

Papers (19)：

Allison Banuelos, Allison Zhang, Hala Berouti, Michelle Baez, Leyla Yılmaz, Nardin Georgeos, Kristopher D Marjon, Masanori Miyanishi, Irving L Weissman. CXCR2 inhibition in G-MDSCs enhances CD47 blockade for melanoma tumor cell clearance. Proceedings of the National Academy of Sciences of the United States of America. 2024. 121. 5. e2318534121
Katsuyuki Nishi, Akiomi Nagasaka, Taro Sakamaki, Kay Sadaoka, Masanori Miyanishi. Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells. Journal of visualized experiments : JoVE. 2023. 195
Katsuyuki Nishi, Taro Sakamaki, Kay Sadaoka, Momo Fujii, Akifumi Takaori-Kondo, James Y Chen, Masanori Miyanishi. Identification of the minimum requirements for successful haematopoietic stem cell transplantation. British journal of haematology. 2022. 196. 3. 711-723
Makoto Iwasaki, Junya Kanda, Yasuyuki Arai, Tadakazu Kondo, Takayuki Ishikawa, Yasunori Ueda, Kazunori Imada, Takashi Akasaka, Akihito Yonezawa, Kazuhiro Yago, et al. Establishment of a Predictive Model for GvHD-free, Relapse-free Survival after Allogeneic HSCT using Ensemble Learning. Blood advances. 2021
Taro Sakamaki, Kevin S Kao, Katsuyuki Nishi, James Y Chen, Kay Sadaoka, Momo Fujii, Akifumi Takaori-Kondo, Irving L Weissman, Masanori Miyanishi. Hoxb5 defines the heterogeneity of self-renewal capacity in the hematopoietic stem cell compartment. Biochemical and biophysical research communications. 2021. 539. 34-41

ｍore...

MISC (24)：

宮西正憲. 多様性が求められる未来のARTについて産婦人科出身造血幹細胞研究者が想造する未来医療. 日本IVF学会誌. 2022. 25. 2. 42-42
長谷川大一郎, 田村彰広, 宮西正憲, 小阪嘉之. 小児悪性脳腫瘍の発症・進行メカニズムに関連した単球・マクロファージ系血細胞の多様性に関する基礎的研究. 兵庫県医師会医学雑誌. 2022. 64. 2. 35-35
田村彰広, 井上翔太郎, 森健, 中村さやか, 齋藤敦郎, 神前愛子, 石田敏章, 長谷川大一郎, 小阪嘉之, 宮西正憲. 診断時単球絶対数とリンパ球絶対数の乗算低値は神経芽腫の予後不良に相関する(Low multiplication value of monocyte and lymphocyte count may be associated with poor prognosis in neuroblastoma). 日本小児科学会雑誌. 2022. 126. 2. 230-230
森田寛之, 塚本成幸, 宮西正憲, 竹谷誠. ヒト造血幹細胞機能維持細胞増幅培養液の開発. 組織培養研究. 2021. 39. 1. 93-93
酒巻太郎, 宮西正憲. 造血系における長期造血幹細胞の意義と純化システム. 臨床血液. 2019. 60. 9. 1056-1062

ｍore...

Education (2)：

Work history (6)：

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page